Technical Analysis for 0QOK - Roche Holding AG Participation
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| NR7 | Range Contraction | 0.00% | |
| Narrow Range Bar | Range Contraction | 0.00% | |
| Inside Day | Range Contraction | 0.00% | |
| Gapped Up | Strength | 0.00% | |
| Earnings Movers | Other | 1.03% | |
| Fell Below 20 DMA | Bearish | -0.79% | |
| Expansion Pivot Sell Setup | Bearish Swing Setup | -0.79% | |
| Earnings Movers | Other | -0.79% | |
| Gapped Down | Weakness | -0.79% | |
| 50 DMA Resistance | Bearish | -2.84% |
Get a Trading Assistant
Roche Holding AG Participation Description
Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Switzerland, Germany, the United States, and internationally. The company offers pharmaceutical products in the therapeutic areas of oncology, neuroscience, infectious diseases, immunology, hemophilia, ophthalmology, dermatology, respiratory, anemia, inflammatory and autoimmune, and transplantation. It also offers in vitro tests for the diagnosis of various diseases, such as cancer, cardiovascular, diabetes, Covid-19, hepatitis, human papillomavirus, and other diseases. In addition, the company supplies diagnostic instruments and reagents. It has a research collaboration agreement with Synlogic, Inc. for the discovery of a novel synthetic biotic for the treatment of inflammatory bowel disease (IBD); and strategic agreement with Alnylam Pharmaceuticals, Inc. to develop and commercialize zilebesiran. Roche Holding AG was founded in 1896 and is headquartered in Basel, Switzerland.
Classification
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 298.4 |
| 52 Week Low | 217.095 |
| Average Volume | 113,528 |
| 200-Day Moving Average | 244.73 |
| 50-Day Moving Average | 228.71 |
| 20-Day Moving Average | 223.72 |
| 10-Day Moving Average | 222.34 |
| Average True Range | 3.99 |
| RSI (14) | 43.50 |
| ADX | 14.23 |
| +DI | 23.93 |
| -DI | 31.91 |
| Chandelier Exit (Long, 3 ATRs) | 219.53 |
| Chandelier Exit (Short, 3 ATRs) | 229.06 |
| Upper Bollinger Bands | 230.87 |
| Lower Bollinger Band | 216.57 |
| Percent B (%b) | 0.3 |
| BandWidth | 6.39 |
| MACD Line | -2.21 |
| MACD Signal Line | -2.28 |
| MACD Histogram | 0.0728 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 223.51 | ||||
| Resistance 3 (R3) | 223.34 | 222.27 | 223.06 | ||
| Resistance 2 (R2) | 222.27 | 221.58 | 222.36 | 222.91 | |
| Resistance 1 (R1) | 221.54 | 221.16 | 221.91 | 221.70 | 222.76 |
| Pivot Point | 220.47 | 220.47 | 220.65 | 220.55 | 220.47 |
| Support 1 (S1) | 219.73 | 219.78 | 220.10 | 219.90 | 218.84 |
| Support 2 (S2) | 218.66 | 219.35 | 218.75 | 218.69 | |
| Support 3 (S3) | 217.93 | 218.66 | 218.54 | ||
| Support 4 (S4) | 218.09 |
